Results 191 to 200 of about 5,342,131 (351)
Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz +3 more
wiley +1 more source
Policy options on a sustainable path for clinical trials. [PDF]
Samuel G.
europepmc +1 more source
R. Moynihan, Bjørn-Oliver Magsig
semanticscholar +1 more source
Hospital Readmission After Traumatic Brain Injury Hospitalization in Community‐Dwelling Older Adults
ABSTRACT Objective To examine the risk of hospital readmission after an index hospitalization for TBI in older adults. Methods Using data from the Atherosclerosis Risk in Communities (ARIC) study, we used propensity score matching of individuals with an index TBI‐related hospitalization to individuals with (1) non‐TBI hospitalizations (primary analysis)
Rachel Thomas +7 more
wiley +1 more source
Nationwide Patterns and Predictors of In-Hospital Suicide and Self-Harm in Korea: A Registry-Based Study Using the Korea Patient Safety Reporting and Learning System. [PDF]
Choi SM +5 more
europepmc +1 more source
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu +5 more
wiley +1 more source
Accessing digital harm reduction services -exploring the impact of the "Here4UScotland" application. [PDF]
Strachan G, Daneshvar H, Matheson C.
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Management of behavioural and psychological symptoms of dementia: Nonpharmacologic interventions and medication considerations. [PDF]
Hou V +7 more
europepmc +1 more source
Reforming environmentally harmful subsidies
Annegrete Bruvoll +2 more
openaire +2 more sources

